Patents Assigned to Azora Therapeutics, Inc.
  • Derivatives of aryl hydrocarbon receptor agonists
    Patent number: 11834412
    Abstract: A compound having one of the following structures of Formula (IV) or (V): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, R4, R5 R6, R7, R8, R10, R11a R11b, R12a R12b, X, Y, and Z are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
    Type: Grant
    Filed: March 7, 2023
    Date of Patent: December 5, 2023
    Assignee: Azora Therapeutics, Inc.
    Inventors: Matthew Davidson, Julie Saiki, Robert Lum, Steven R. Schow
  • Topical compositions and methods for treating inflammatory skin diseases
    Patent number: 11154533
    Abstract: Compositions and methods for treating skin conditions, ailments or diseases, such as autoinflammatory skin diseases such as psoriasis, dermatitis, pyoderma gangrenosum, palmoplantar pustulosis, prurigo nodularis and/or hidradenitis suppurativa, are described. The compositions comprise an agent that modulates the aryl hydrocarbon receptor, in particular an agent that agonizes the receptor. In one embodiment, the agent is indigo or a derivative of indigo, such as indirubin.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: October 26, 2021
    Assignee: Azora Therapeutics, Inc.
    Inventors: Matthew Davidson, Julie Saiki, Johan Andreasson